Rapid neurological deterioration in a patient with multiple sclerosis treated with systemic interleukin-2 and interferon-alpha 2b for metastatic renal cell carcinoma.
Open Access
- 1 January 1997
- journal article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 62 (1) , 100
- https://doi.org/10.1136/jnnp.62.1.100
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions.The Journal of Experimental Medicine, 1995
- Subacute combined degeneration of the spinal cord: MRI detection of preferential involvement of the posterior columns in a childPediatric Radiology, 1995
- Multiple Sclerosis: Immune System Molecule Expression in the Central Nervous SystemJournal of Neuropathology and Experimental Neurology, 1994
- Reactivation of rheumatoid arthritis during continuous infusion of interleukin 2: evidence of lymphocytic control of rheumatoid disease.BMJ, 1990
- Interleukin 2 and PsoriasisArchives of Dermatology, 1988